期刊文献+

造影剂肾病的危险因素及预防 被引量:12

The Risk Factors and Prevention of Contrast-induced Nephropathy
原文传递
导出
摘要 随着造影剂在放射诊断技术和介入诊治技术中的应用日趋广泛,造影剂肾病(CIN)已成为一种不容忽视的医源性肾脏疾病,是院内获得性急性肾衰竭的常见原因,且发病率和病死率逐年增加。造影剂肾病延长患者的住院时间,增加患者的医疗费用,部分患者出现不可逆的肾功损害,存在很高的死亡风险。目前CIN尚无有效的治疗方法,也无绝对有效的措施完全阻止该病的发生,只能通过正确认识其危险因素、辨别高危患者并采取适当的预防措施来降低CIN患病风险,改善患者预后。目前已知的造影剂肾病的危险因素包括已存在肾脏损害、糖尿病、高龄、使用高渗离子型造影剂等,预防措施也有一定的进展,水化、某些药物等均有一定的预防作用。本文主要对造影剂肾病的危险因素及预防措施进行综述。 with the development of interventional radiological procedures, contrast-induced nephropathy(CIN) has been a common serious kidney disease. It is also a common cause of hospital-acquired acute renal failure, and the morbidity and mortality are increasing year by year. Contrast-induced nephropathy not only extend hospitalization time but also increase patients’ medical costs.Some patients with irreversible renal function damage has a high risk of death. Nowadays contrast-induced nephropathy has no specific treatment and no efficient measures to prevent the occurrence of the disease completely. So identifying high-risk patients and taking appropriate preventive measures are the key to reduce this disease and improve the prognosis. Its known risk factors include existing kidney damage, diabetes, advanced age, using high osmotic ionic contrast medium, etc and preventive measures also consist of hydration,certain drugs, etc. The purpose of this report is mainly to review the risk factors and preventive measures of the disease.
出处 《现代生物医学进展》 CAS 2015年第25期4997-5000,共4页 Progress in Modern Biomedicine
关键词 造影剂肾病 危险因素 预防 Contrast-induced nephropathy Risk factors Prevention
  • 相关文献

参考文献41

  • 1Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency [J]. Am J Kidney Dis, 2002, 39(5): 930-936.
  • 2Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy:a clinical and evidence- based approach[J]. Circulation, 2006, 113:179 9-1806.
  • 3Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis[J]. JAMA, 1996, 275:1489.
  • 4Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence- based approach[J]. Circulation, 2006, 113:179 9-1806.
  • 5McCullough P. Outcomes of contrast-induced nephropathy:experience in patients undergoing cardiovascular intervention [J]. Catheter Cardiovasc Interv, 2006, 67:335-343.
  • 6Thomsen HS. Guidelines for Contrast Media from the Eurolean Society of Urogenital Radiology [J]. American Journal of Roentgenology, 2003, 181:1463-1471.
  • 7Barrett B J, Parffey PS. Clinical practice. Preventing nephropathy induced by contrast medium[J]. N Engl J Med, 2006, 354(4): 379-386.
  • 8Toprak O, Cirit M. Risk factors and therapy strategies for contrast- induced nephropathy[J]. Pen Fail, 2006, 28:365-381.
  • 9MeCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy [J]. Am J Cardiol, 2006, 98: 5K-3K.
  • 10Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies[J]. Can Med Assoc J, 2005, 172(11): 1461-1471.

同被引文献123

  • 1陈辉,郭卿,杨波.药师参与碘克沙醇致迟发性过敏反应治疗1例[J].武警医学,2019(12):1091-1092. 被引量:2
  • 2骆金铠,于桂香.造影剂肾病的危险因素及护理预防[J].中华护理杂志,2007,42(6):546-548. 被引量:63
  • 3ANDREUCCI M,FAGA T,PISANI A,et al.Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors[J].Scientific World Journal,2014:823169.
  • 4PALEVSKY P M,LIU K D,BROPHY P D,et al.KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J].Am J Kidney Dis,2013,61(5):649-672.
  • 5STACUL F,VAN DER MOLEN A J,REIMER P,et al.Contrast induced nephropathy:updated ESUR Contrast Media Safety Committee guidelines[J].Eur Radio1,2011,21(12):2527-2541.
  • 6Ozsvath K J,Darling R C III.Renal protection:preconditioning for the prevention of contrast-induced nephropathy[J].Seminars In Vascular Surgery,2013,26(4):144-149.
  • 7Kim JE,Lee JM,Baek JH,et al.Initial assessment of dualenergy CT in patients with gallstones or bile duct stones:Can virtual nonenhaneed images replace true nonenhaneeed images[J]? AIR AM J Roentgenol,2012,198(4):817-824.
  • 8Postma AA,Hofman PA,Stadler AA,et al.Dual-energy CT of the brain and intracranial vessels[J].AJR Am JRoentgenol,2012,199(5 S):S26-S33.
  • 9Johnson TR,Krauss B,Sedlmair M,et al.Material differentiation by dual energy CT;Initial experience[J].Eur Radiol,2007,17(6): 1520-1517.
  • 10Bogot NR,Fingerle A,Shaham D,et al.Image quality of low- energy pulmonary CT angiograghy: Comparison with standard CT[J].AJR Roentgenol,2012,197(2):W273-278.

引证文献12

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部